203 related articles for article (PubMed ID: 11922209)
1. New bone-seeking agent: animal study of Tc-99m-incadronate.
Shigematsu M; Shomi S; Iwao H; Ochi H
Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
[TBL] [Abstract][Full Text] [Related]
2. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
3. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
[TBL] [Abstract][Full Text] [Related]
6. Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.
Lin WY; Lin CP; Yeh SJ; Hsieh BT; Tsai ZT; Ting G; Yen TC; Wang SJ; Knapp FF; Stabin MG
Eur J Nucl Med; 1997 Jun; 24(6):590-5. PubMed ID: 9169563
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.
Rennen HJ; Boerman OC; Oyen WJ; Corstens FH
J Nucl Med; 2003 Sep; 44(9):1502-9. PubMed ID: 12960199
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of 99mTc-labeled imidazolyl-containing diphosphonic acid as a novel bone imaging agent.
Qiu L; Cheng W; Lin J; Zhang S; Luo S
J Labelled Comp Radiopharm; 2013 Sep; 56(11):573-80. PubMed ID: 24285189
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
11. A new bisphosphonate-containing (99m)Tc(I) tricarbonyl complex potentially useful as bone-seeking agent: synthesis and biological evaluation.
Palma E; Oliveira BL; Correia JD; Gano L; Maria L; Santos IC; Santos I
J Biol Inorg Chem; 2007 Jun; 12(5):667-79. PubMed ID: 17333301
[TBL] [Abstract][Full Text] [Related]
12. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
Mochizuki T; Kuge Y; Zhao S; Tsukamoto E; Hosokawa M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
[TBL] [Abstract][Full Text] [Related]
13. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
Ghiron J; Volkert WA; Garlich J; Holmes RA
Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
[TBL] [Abstract][Full Text] [Related]
14. The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m.
Asikoglu M; Durak FG
Appl Radiat Isot; 2009 Sep; 67(9):1616-21. PubMed ID: 19457677
[TBL] [Abstract][Full Text] [Related]
15.
Rashed HM; Marzook FA; Farag H
Radiol Med; 2016 Dec; 121(12):935-943. PubMed ID: 27586132
[TBL] [Abstract][Full Text] [Related]
16. A novel (99m)Tc-labeled diphosphonic acid as potential bone seeking agent: synthesis and biological evaluation.
Qiu L; Cheng W; Lin J; Zhang S; Luo S
Curr Radiopharm; 2013 Mar; 6(1):28-35. PubMed ID: 23256753
[TBL] [Abstract][Full Text] [Related]
17. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
[TBL] [Abstract][Full Text] [Related]
19. [A new radiopharmaceutical for bone imaging: experimental study of 99mTc-HEDTMP].
Hu S; Deng H; Jiang S; Luo S; Lei Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):811-5. PubMed ID: 20842850
[TBL] [Abstract][Full Text] [Related]
20. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]